Recombinant Human Nectin-1 / PVRL1 / CD111 Protein, Fc Tag, 100µg

Background
Poliovirus receptor-related protein 1 (PVRL1) is also known as Herpes virus entry mediator C (HveC), Herpesvirus Ig-like receptor (HIgR), Nectin-1, CD antigen CD111, PVRL1 / Nectin-1 / CD111 belongs to the nectin family. PVRL1 / Nectin-1 is a membrane protein with three extracellular immunoglobulin domains, a single transmembrane helix and a cytoplasmic tail. The protein can mediate Ca2+-independent cellular adhesion further characterizing it as IgSF cell adhesion molecule (IgSF CAM). PVRL1 is adhesion molecule found in a wide range of tissues. PVRL1 / Nectin-1 promotes cell-cell contacts by forming homophilic or heterophilic trans-dimers. Heterophilic interactions have been detected between PVRL1/nectin-1 and PVRL3/nectin-3 and between PVRL1/nectin-1 and PVRL4/nectin-4.

Source
Recombinant Human Nectin-1, Fc Tag (PV1-H5253) is expressed from human 293 cells (HEK293). It contains AA Gln 31 - Thr 334 (Accession # Q15223-1).
Predicted N-terminus: Gln 31

Molecular Characterization
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 60.4 kDa. The protein migrates as 66-90 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin
Less than 1.0 EU per μg by the LAL method.

Purity
>95% as determined by SDS-PAGE.

Formulation
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.

Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70^°C for 3 months under sterile conditions after reconstitution.

Bioactivity
Please refer to product data sheet.

Clinical and Translational Updates

(1) "Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS"
Nanamiya, Takane, Yamaguchi et al
Oncol Rep (2024) 51 (1)
(2) "Nectin-4 regulates cellular senescence-associated enlargement of cell size"
Katasho, Nagano, Iwasaki et al
Sci Rep (2023) 13 (1), 21602
(3) "Nectin-4 has emerged as a compelling target for breast cancer"
Wang, Sun, Chen et al
Eur J Pharmacol (2023) 960, 176129
Showing 1-3 of 840 papers.